Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy

scientific article published on 6 May 2015

Derivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy is …
instance of (P31):
scholarly articleQ13442814

External links are
P6179Dimensions Publication ID1023941249
P356DOI10.1186/S12920-015-0091-3
P932PMC publication ID4434538
P698PubMed publication ID25944280
P5875ResearchGate publication ID276072474

P2093author name stringAvrum Spira
Anil Vachani
Gerard A Silvestri
Jerome S Brody
Marc E Lenburg
Adam C Gower
J Scott Ferguson
Michael R Elashoff
Duncan H Whitney
Kate Porta-Smith
P2860cites workNova, the paraneoplastic Ri antigen, is homologous to an RNA-binding protein and is specifically expressed in the developing motor systemQ24317395
Evolving gene/transcript definitions significantly alter the interpretation of GeneChip dataQ24537656
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resourcesQ27860739
Molecular classification of cancer: class discovery and class prediction by gene expression monitoringQ27861072
Exploration, normalization, and summaries of high density oligonucleotide array probe level dataQ27861098
Reduced lung-cancer mortality with low-dose computed tomographic screeningQ28241954
Interventional pulmonary procedures: Guidelines from the American College of Chest Physicians.Q51674170
Airway epithelial gene expression in the diagnostic evaluation of smokers with suspect lung cancerQ57077976
Molecular Signature of Smoking in Human Lung TissuesQ57891574
Involvement of gicerin, a cell adhesion molecule, in tracheal development and regenerationQ71872018
Trial to establish an animal model of paraneoplastic cerebellar degeneration with anti-Yo antibody. 1. Mouse strains bearing different MHC molecules produce antibodies on immunization with recombinant Yo protein, but do not cause Purkinje cell lossQ72331500
Upregulation of MCAM in primary bronchial epithelial cells from patients with COPDQ79094861
Ri antibodies in patients with breast, ovarian or small cell lung cancer determined by a sensitive immunoprecipitation techniqueQ82336620
Genomics of smoking exposure and cessation: lessons for cancer prevention and treatmentQ83177871
Population-based risk for complications after transthoracic needle lung biopsy of a pulmonary nodule: an analysis of discharge recordsQ30503294
Screening for lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.Q30543321
Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke.Q33976469
Identification and validation of highly frequent CpG island hypermethylation in colorectal adenomas and carcinomasQ34170505
The role of gicerin, a novel cell adhesion molecule, in development, regeneration and neoplasiaQ34238483
Establishing the diagnosis of lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesQ34708111
Up-regulation of MUC18 in airway epithelial cells by IL-13: implications in bacterial adherenceQ34985617
Reversible and permanent effects of tobacco smoke exposure on airway epithelial gene expressionQ36643310
Electromagnetic navigation diagnostic bronchoscopy: a prospective studyQ37110288
The field of tissue injury in the lung and airwayQ37250499
Transcriptomic architecture of the adjacent airway field cancerization in non-small cell lung cancerQ37696458
Latest advances in advanced diagnostic and therapeutic pulmonary proceduresQ38064775
A new Mel-CAM (CD146)-specific monoclonal antibody, MN-4, on paraffin-embedded tissueQ38470174
TSPAN2 is involved in cell invasion and motility during lung cancer progression.Q39004980
Cerebellar degeneration-related autoantigen 1 (CDR1) gene expression in prostate cancer cell lines.Q39040306
Prevalence of benign disease in patients undergoing resection for suspected lung cancerQ44007746
Selective expression of Purkinje-cell antigens in tumor tissue from patients with paraneoplastic cerebellar degenerationQ48949272
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P921main subjectlung cancerQ47912
P304page(s)18
P577publication date2015-05-06
P1433published inBMC Medical GenomicsQ15754662
P1476titleDerivation of a bronchial genomic classifier for lung cancer in a prospective study of patients undergoing diagnostic bronchoscopy
P478volume8

Reverse relations

cites work (P2860)
Q36817737A Bronchial Genomic Classifier for the Diagnostic Evaluation of Lung Cancer
Q34558199A Review of Pulmonary Toxicity of Electronic Cigarettes in the Context of Smoking: A Focus on Inflammation.
Q33623634A lung cancer risk classifier comprising genome maintenance genes measured in normal bronchial epithelial cells
Q45944052Alterations in Bronchial Airway miRNA Expression for Lung Cancer Detection.
Q35937945Analytical performance of a bronchial genomic classifier
Q37000598Antimicrobial Resistance Prediction in PATRIC and RAST.
Q62492568Biomarkers in Lung Cancer Screening: Achievements, Promises, and Challenges
Q92057664Biomarkers of Exposure and Effect in the Lungs of Smokers, Nonsmokers, and Electronic Cigarette Users
Q53275538Detecting the Presence and Progression of Premalignant Lung Lesions via Airway Gene Expression.
Q47157939Detection of tumor-derived DNA dispersed in the airway improves the diagnostic accuracy of bronchoscopy for lung cancer
Q91062631Gene network approach reveals co-expression patterns in nasal and bronchial epithelium
Q49572202Genome-wide gene expression changes in the normal-appearing airway during the evolution of smoking-associated lung adenocarcinoma.
Q38651767Genomic approaches to accelerate cancer interception
Q36019027Impact of a bronchial genomic classifier on clinical decision making in patients undergoing diagnostic evaluation for lung cancer
Q54763099Lung Cancer Field Cancerization: Implications for Screening by Low-Dose Computed Tomography.
Q63881018Machine Learning Methods as a Tool for Predicting Risk of Illness Applying Next‐Generation Sequencing Data
Q64097509Molecular subtyping reveals immune alterations associated with progression of bronchial premalignant lesions
Q55440469PCDHGA12 methylation biomarker in bronchial washing specimens as an adjunctive diagnostic tool to bronchoscopy in lung cancer.
Q42139806Progress and prospects of early detection in lung cancer
Q26747819Risk factors assessment and risk prediction models in lung cancer screening candidates
Q38855670Shared Gene Expression Alterations in Nasal and Bronchial Epithelium for Lung Cancer Detection
Q41619467Smoking and Lung Cancer: A Geo-Regional Perspective
Q26750970Soluble Epidermal Growth Factor Receptors (sEGFRs) in Cancer: Biological Aspects and Clinical Relevance
Q49791858The Airway Transcriptome as a Biomarker for Early Lung Cancer Detection
Q37417542The airway epithelium undergoes metabolic reprogramming in individuals at high risk for lung cancer

Search more.